[Federal Register Volume 78, Number 33 (Tuesday, February 19, 2013)]
[Notices]
[Pages 11650-11651]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-03612]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC),
announces the following meeting of the aforementioned committee:
Board Public Meeting Times and Dates (All times are Eastern
Time): 9:45 a.m.-6:00 p.m., March 12, 2013.
Public Comment Times and Dates (All times are Eastern Time):
6:00 p.m.-7:00 p.m.,* March 12, 2012.
*Please note that the public comment period may end before the
times indicated, following the last call for comments. Members of
the public who wish to provide public comments should plan to attend
public comment sessions at the start times listed.
Place: Augusta Marriott Hotel, Two Tenth Street, Augusta, GA
30901; Phone: 706-722-8900; Fax: 706-724-0044. Audio Conference Call
via FTS Conferencing. The USA toll-free, dial-in number is 1-866-
659-0537 with a pass code of 9933701.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 150 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing
advice on the development of probability of causation guidelines
which have been promulgated by the Department of Health and Human
Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final
rule, advice on the scientific validity and quality of dose
estimation and reconstruction efforts being performed for purposes
of the compensation program, and advice on petitions to add classes
of workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements
this responsibility for CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and will expire on August 3,
2013.
Purpose: This Advisory Board is charged with (a) providing
advice to the Secretary, HHS, on the development of guidelines under
Executive Order 13179; (b) providing advice to the Secretary, HHS,
on the scientific validity and quality of dose reconstruction
efforts performed for this program; and (c) upon request by the
Secretary, HHS, advise the Secretary on whether there is a class of
employees at any Department of Energy facility who were exposed to
radiation but for whom it is not feasible to estimate their
radiation dose, and on whether there is reasonable likelihood that
such radiation doses may have endangered the health of members of
this class.
Matters To Be Discussed: The agenda for the Advisory Board
meeting includes: NIOSH Program Update; Department of Labor Program
Update; Department of Energy Program Update; SEC petitions for:
Brookhaven National Laboratory (1994-2007), Baker Brothers (Toledo,
OH; 1945-1996); Procedures Review Subcommittee Report; SEC Issues
Work Group Report on ``Sufficient Accuracy''; Savannah River Site
Work Group Update; SEC Petitions Update; and Board Work Sessions.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may
be submitted in accordance with the redaction policy provided below.
Any written comments received will be provided at the meeting and
should be submitted to the contact person below well in advance of
the meeting.
Policy on Redaction of Board Meeting Transcripts (Public
Comment): (1) If a person making a comment gives his or her name, no
attempt will be made to redact that name. (2) NIOSH will take
reasonable steps to ensure that individuals making public comment
are aware of the fact that their comments (including their name, if
provided) will appear in a transcript of the meeting posted on a
public Web site. Such reasonable steps include: (a) A statement read
at the start of each public comment period stating that transcripts
will be posted and names of speakers will not be redacted; (b) A
printed copy of the statement mentioned in (a) above
[[Page 11651]]
will be displayed on the table where individuals sign up to make
public comments; (c) A statement such as outlined in (a) above will
also appear with the agenda for a Board Meeting when it is posted on
the NIOSH Web site; (d) A statement such as in (a) above will appear
in the Federal Register Notice that announces Board and Subcommittee
meetings. (3) If an individual in making a statement reveals
personal information (e.g., medical information) about themselves
that information will not usually be redacted. The NIOSH Freedom of
Information Act (FOIA) coordinator will, however, review such
revelations in accordance with the FOIA and the Federal Advisory
Committee Act and if deemed appropriate, will redact such
information. (4) All disclosures of information concerning third
parties will be redacted. (5) If it comes to the attention of the
DFO that an individual wishes to share information with the Board
but objects to doing so in a public forum, the DFO will work with
that individual, in accordance with the Federal Advisory Committee
Act, to find a way that the Board can hear such comments.
Contact Person for More Information: Theodore Katz, DFO, NIOSH,
CDC, 1600 Clifton Road, MS E-20, Atlanta, GA 30333, telephone: (513)
533-6800, toll free: 1-800-CDC-INFO, email: [email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office Centers for Disease
Control and Prevention.
[FR Doc. 2013-03612 Filed 2-15-13; 8:45 am]
BILLING CODE 4163-18-P